Target | |
---|---|
Synonyms | TF; TFA; F3 |
Description | Recombinant Cynomolgus CD142 protein with C-terminal 10×His tag |
Delivery | In Stock |
Uniprot ID | A0A2K5VX02 |
Expression Host | HEK293 |
Tag | C-10×His tag |
Molecular Characterization | CD142(Ser33-Glu252) 10×His tag |
Molecular Weight | The protein has a predicted molecular mass of 26.4 kDa after removal of the signal peptide. The apparent molecular mass of cCD142-His is approximately 35-55 kDa due to glycosylation. |
Purity | The purity of the protein is greater than 85% as determined by SDS-PAGE and Coomassie blue staining. |
Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
Background | This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020] |
Usage | Research use only |
Conjugate | Unconjugated |
Cynomolgus CD142 Protein, His Tag
Price: 10μg $120.00 ; 50μg $450.00 ; 100μg $660.00
Product Data
Images
Figure 1. Cynomolgus CD142 Protein, His Tag on SDS-PAGE under reducing condition.
Related Products
Biosimilar reference antibodies
SKU: BME100124P Target: CD142
Application: Flow Cyt
Price: 100 test $192.00
DiSliceX
SKU: SLI100005 Target: ADAM9, CD142, CD63, CDH1, CDH3, EGFR, GPR87, JAM-A, MICA, NECTIN4, PCSK, PSCA, Trop2
Application: IHC
Price: 2 slides $129.00
Biosimilar reference antibodies
SKU: BME100661 Target: CD142
Application: N/A
Price: 50μg $82.00 ; 100 μg $162.00
Biosimilar reference antibodies
SKU: BME100124B Target: CD142
Application: ELISA
Price: 50μg $99.00 ; 100 μg $199.00
DiSliceX
SKU: SLI100016 Target: AXL, CD142, CD63, CD73, CD99, HBEGF, LGALS1, NRG1, ROR1, TGFBR2, VEGFA
Application: IHC
Price: 2 slides $129.00